In the BioHarmony Drug Report Database

"Preview" Icon

Carglumic acid

Carbaglu (carglumic acid) is a small molecule pharmaceutical. Carglumic acid was first approved as Carbaglu on 2003-01-24. It is used to treat hyperammonemia in the USA. It has been approved in Europe to treat hyperammonemia, inborn errors amino acid metabolism, and propionic acidemia.

 

Trade Name

 

Carbaglu
 

Common Name

 

carglumic acid
 

ChEMBL ID

 

CHEMBL1201780
 

Indication

 

hyperammonemia, inborn errors amino acid metabolism, propionic acidemia
 

Drug Class

 

Image (chem structure or protein)

Carglumic acid structure rendering